Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14775220 | 0.85 | ALDH1A1 (0.50) | ALDH1A1LMNACES2CES1TDP1 | |
| SCHEMBL757521 | 0.84 | ALDH1A1 (0.46) | ALDH1A1LMNACES2CES1TDP1 | |
| SCHEMBL13777831 | 0.84 | CES2 (0.42) | ALDH1A1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL4209048 | 0.83 | TDP1 (0.57) | ALDH1A1LMNACES2CES1TDP1 | |
| SCHEMBL14775222 | 0.83 | ALDH1A1 (0.52) | ALDH1A1LMNACES2CES1TDP1 | |
| SCHEMBL9970923 | 0.83 | ALDH1A1 (0.41) | ALDH1A1LMNACES2CES1TDP1 | |
| SCHEMBL8760128 | 0.82 | CES2 (0.46) | ALDH1A1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL280538 | 0.81 | ELANE (0.47) | ALDH1A1LMNACES2CES1TDP1 | |
| SCHEMBL13777829 | 0.81 | CYP2A6 (0.43) | ALDH1A1LMNACES2CES1TDP1 | |
| SCHEMBL3385266 | 0.80 | MAPT (0.61) | LMNACES2CES1NPSR1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1329497-B1 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH & CIE (CH) | 2010-12-01 | — | — | EP | claimed |
| US-20030144173-A1 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-31 | — | — | US | claimed |
| EP-1329497-A2 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144173-A1 | Utilization of unsaturated esters as perfuming ingredients | CPT1A, FASN, FFAR3 | ALDH1A1 1192/4885LMNA 3696/4885CES2 1087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.